Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Inovio Pharmaceuticals Inc (NASDAQ: INO) was $2.17 for the day, up 2.36% from the previous closing price of $2.12. In other words, the price has increased by $2.36 from its previous closing price. On the day, 0.73 million shares were traded.
Ratios:
Our analysis of INO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.63 and its Current Ratio is at 2.63. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on May 14, 2024, initiated with a Overweight rating and assigned the stock a target price of $20.
On January 25, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $4.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 284.23 while its Price-to-Book (P/B) ratio in mrq is 1.55.
Stock Price History:
Over the past 52 weeks, INO has reached a high of $12.33, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 17.91%, while the 200-Day Moving Average is calculated to be -37.63%.
Shares Statistics:
A total of 36.67M shares are outstanding, with a floating share count of 36.39M. Insiders hold about 0.79% of the company’s shares, while institutions hold 37.18% stake in the company.
